2nd Quarter - Report

WEST FRONT STRATEGIES LLC for VIATRIS INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to access to biosimilar biological products in Medicare Part B, including the Increasing Access to Biosimilars Act, H.R. 1352.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1352 (118th)

Labor Issues/Antitrust/Workplace LBR

Monitor issues related to antitrust and competition.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Issues related to e-labeling; monitor issues related to Pharmacy Benefit Manager Transparency Act, S.127.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 127 (118th)

Copyright/Patent/Trademark CPT

Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 142 (118th), H.R. 1717 (118th), S. 150 (118th), S. 2220 (118th), S. 2780 (118th), H.R. 4370 (118th), S. 79 (118th), H.R. 5429 (118th)

Budget/Appropriations BUD

Medicaid Rebate provision of the Bipartisan Budget Act of 2015 (CPI Penalty).

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503; and Presidents Emergency Plan for AIDS Relief Reauthorization.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1503 (118th), S. 775 (118th), H.R. 3839 (118th), S. 1120 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.